Drugs / follicle stimulating hormone
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT00006156 | Aug 2000 → Jan 2012 | primary ovarian failure | Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | Completed | No outcome recorded |
Evidence & citations 5 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | follicle stimulating hormone | “They will then receive an injection of a synthetic form of follicle stimulating hormone (FSH), a hormone the body makes normally.” NCT00006156 ↗ |
| Known as | FSH | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00006156 ↗ |
| Action | Activate | “FSH stimulates inhibin B production” NCT00006156 ↗ |
| Modality | Protein / enzyme biologic | “human recombinant FSH” NCT00006156 ↗ |
| Route | Subcutaneous | “single subcutaneous injection” NCT00006156 ↗ |